In Search Of Risk-Sharing Partners In China, India, Pharma Says

SAN FRANCISCO - Cost relief in China and India is paying off for big pharma, which is scrambling for pipelines in a world where in-license deals become ever less practical

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip